DOX Quote, Financials, Valuation and Earnings

Intellinetics has a net margin of 14.47% compared to Amdocs's net margin of -17.13%. Amdocs's return on equity of 15.34% beat Intellinetics's return on equity of -10.61%.

Amdocs has a consensus price target of $102.17, signalling upside risk potential of 14.57%. On the other hand Intellinetics has an analysts' consensus of $16.50 which suggests that it could grow by 22.68%. Given that Intellinetics has higher upside potential than Amdocs, analysts believe Intellinetics is more attractive than Amdocs.

Amdocs has a beta of 0.515, which suggesting that the stock is 48.456% less volatile than S&P 500. In comparison Intellinetics has a beta of 0.510, suggesting its less volatile than the S&P 500 by 48.997%.

Amdocs has a quarterly dividend of $0.53 per share corresponding to a yield of 2.26%. Intellinetics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. Intellinetics pays out -- of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.1B, which are larger than Intellinetics quarterly revenues of $4.2M. Amdocs's net income of $163.2M is higher than Intellinetics's net income of -$727.6K. Notably, Amdocs's price-to-earnings ratio is 18.77x while Intellinetics's PE ratio is 248.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 2.10x versus 3.30x for Intellinetics. Usually stocks with elevated PS ratios are considered overvalued.

Sabre has a net margin of 14.47% compared to Amdocs's net margin of 4.55%. Amdocs's return on equity of 15.34% beat Sabre's return on equity of --.

Amdocs has a consensus price target of $102.17, signalling upside risk potential of 14.57%. On the other hand Sabre has an analysts' consensus of $4.66 which suggests that it could grow by 53.34%. Given that Sabre has higher upside potential than Amdocs, analysts believe Sabre is more attractive than Amdocs.

Amdocs has a beta of 0.515, which suggesting that the stock is 48.456% less volatile than S&P 500. In comparison Sabre has a beta of 1.400, suggesting its more volatile than the S&P 500 by 40.013%.

Amdocs has a quarterly dividend of $0.53 per share corresponding to a yield of 2.26%. Sabre offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. Sabre pays out -- of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.1B, which are larger than Sabre quarterly revenues of $776.6M. Amdocs's net income of $163.2M is higher than Sabre's net income of $35.3M. Notably, Amdocs's price-to-earnings ratio is 18.77x while Sabre's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 2.10x versus 0.40x for Sabre. Usually stocks with elevated PS ratios are considered overvalued.

Twilio has a net margin of 14.47% compared to Amdocs's net margin of 1.71%. Amdocs's return on equity of 15.34% beat Twilio's return on equity of -0.4%.

Amdocs has a consensus price target of $102.17, signalling upside risk potential of 14.57%. On the other hand Twilio has an analysts' consensus of $130.71 which suggests that it could grow by 7%. Given that Amdocs has higher upside potential than Twilio, analysts believe Amdocs is more attractive than Twilio.

Amdocs has a beta of 0.515, which suggesting that the stock is 48.456% less volatile than S&P 500. In comparison Twilio has a beta of 1.302, suggesting its more volatile than the S&P 500 by 30.173%.

Amdocs has a quarterly dividend of $0.53 per share corresponding to a yield of 2.26%. Twilio offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. Twilio pays out -- of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.1B, which are smaller than Twilio quarterly revenues of $1.2B. Amdocs's net income of $163.2M is higher than Twilio's net income of $20M. Notably, Amdocs's price-to-earnings ratio is 18.77x while Twilio's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 2.10x versus 4.30x for Twilio. Usually stocks with elevated PS ratios are considered overvalued.

WidePoint has a net margin of 14.47% compared to Amdocs's net margin of -2.12%. Amdocs's return on equity of 15.34% beat WidePoint's return on equity of -14.61%.

Amdocs has a consensus price target of $102.17, signalling upside risk potential of 14.57%. On the other hand WidePoint has an analysts' consensus of $7.50 which suggests that it could grow by 135.85%. Given that WidePoint has higher upside potential than Amdocs, analysts believe WidePoint is more attractive than Amdocs.

Amdocs has a beta of 0.515, which suggesting that the stock is 48.456% less volatile than S&P 500. In comparison WidePoint has a beta of 1.603, suggesting its more volatile than the S&P 500 by 60.329%.

Amdocs has a quarterly dividend of $0.53 per share corresponding to a yield of 2.26%. WidePoint offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Amdocs pays 42.98% of its earnings as a dividend. WidePoint pays out -- of its earnings as a dividend. Amdocs's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Amdocs quarterly revenues are $1.1B, which are larger than WidePoint quarterly revenues of $34.2M. Amdocs's net income of $163.2M is higher than WidePoint's net income of -$724.1K. Notably, Amdocs's price-to-earnings ratio is 18.77x while WidePoint's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Amdocs is 2.10x versus 0.21x for WidePoint. Usually stocks with elevated PS ratios are considered overvalued.